Pillstats
Rx only · Tablet, Extended Release · Oral

Methylphenidate Hydrochloride

Brands: Concerta · Relexxii · Methylphenidate Hydrochloride

13 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US60 NDCs
13 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN06BA04
RxCUI (US)6901
US makers14 labelers
Packages68
DEA / ScheduleCII

US acquisition costNADAC · per unit

Average across 41 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$3.41$6.81$10.22$13.63Oct 2025Mar 2026Jul 2026
$6.593
Latest avg · Jul 22, 2026
-44%
Since Oct 22, 2025
13
Active US suppliers
28%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

413K825K1.2M1.7M2025 Q12025 Q22025 Q32025 Q42026 Q1
1.3M
Rx · 2026 Q1
41.5M
Units dispensed
-3%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it13 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Vertical Pharmaceuticals, LLCunknown11SUPPLYING
Trigen Laboratories, LLCunknown8SUPPLYING
Lannett Company, Inc.unknown8SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown6SUPPLYING
Golden State Medical Supply, Inc.unknown6SUPPLYING
SpecGx LLCunknown5SUPPLYING
XLCare Pharmaceuticals Inc.unknown4SUPPLYING
Camber Pharmaceuticals, Inc.unknown4SUPPLYING
Janssen Pharmaceuticals, Inc.unknown4SUPPLYING
American Health Packagingunknown4SUPPLYING
Granules Pharmaceuticals Incunknown4SUPPLYING
Bryant Ranch Prepackrepackager2SUPPLYING
NorthStar Rx LLCunknown1SUPPLYING
Dr.Reddy's laboratories Limitedunknown1EXITED 2026

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jun 17, 2024
    RECALLRecall (Class II): Methylphenidate Hydrochloride, Extended-release Tablets, USP, 36mg, 100-count Bottle, Rx Only, Manufactured for: Trigen…

    Failed dissolution specifications: this product is being recalled due to this batch not meeting dissolution specifications. — Recalling firm: Trigen Laboratories — Nationwide in the USA

  • Jul 26, 2023
    SHORTAGEDrug shortage: Methylphenidate Hydrochloride Tablet, Extended Release (Janssen Pharmaceuticals)

    Methylphenidate Hydrochloride Tablet, Extended Release — reported in shortage by Janssen Pharmaceuticals. Therapeutic category: Psychiatry.

  • Jul 26, 2023
    SHORTAGEDrug shortage: Methylphenidate Hydrochloride Tablet, Extended Release (Lannett Company, Inc.)

    Methylphenidate Hydrochloride Tablet, Extended Release — reported in shortage by Lannett Company, Inc.. Therapeutic category: Psychiatry.

  • Jul 26, 2023
    SHORTAGEDrug shortage: Methylphenidate Hydrochloride Tablet, Extended Release (Trigen Laboratories, LLC)

    Methylphenidate Hydrochloride Tablet, Extended Release — reported in shortage by Trigen Laboratories, LLC. Therapeutic category: Psychiatry.

  • Jul 26, 2023
    SHORTAGEDrug shortage: Methylphenidate Hydrochloride Tablet, Extended Release (Sun Pharmaceutical Industries, Inc.)

    Methylphenidate Hydrochloride Tablet, Extended Release — reported in shortage by Sun Pharmaceutical Industries, Inc.. Therapeutic category: Psychiatry.

  • Jul 26, 2023
    SHORTAGEDrug shortage: Methylphenidate Hydrochloride Tablet, Extended Release (Vertical Pharmaceuticals, LLC)

    Methylphenidate Hydrochloride Tablet, Extended Release — reported in shortage by Vertical Pharmaceuticals, LLC. Therapeutic category: Psychiatry.

  • Feb 28, 2018
    RECALLRecall (Class III): Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, Rx only, Trigen Laboratories, LLC…

    Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet. — Recalling firm: Osmotica Pharmaceutical Corp — Nationwide in the USA

  • Dec 18, 2017
    RECALLRecall (Class III): Methylphenidate Hydrochloride Extended-release Tablets, USP 54 mg, 100-count bottles, Rx Only, Trigen Laboratories, LLC…

    Subpotent Drug — Recalling firm: Osmotica Pharmaceutical Corp — Nationwide

  • Dec 18, 2017
    RECALLRecall (Class III): Methylphenidate Hydrochloride Extended-release Tablets, USP 27 mg, 100-count bottles, Rx Only, Trigen Laboratories, LL…

    Subpotent Drug — Recalling firm: Osmotica Pharmaceutical Corp — Nationwide